ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
24 hedge funds and large institutions have $1.93M invested in Oncternal Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
24
Holding in Top 10
–
Calls
$129K
Puts
–
Top Buyers
| 1 | +$468K | |
| 2 | +$97.9K | |
| 3 | +$87K | |
| 4 |
Morgan Stanley
New York
|
+$45K |
| 5 |
Goldman Sachs
New York
|
+$38K |
Top Sellers
| 1 | -$282K | |
| 2 | -$214K | |
| 3 | -$163K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$123K |
| 5 |
State Street
Boston,
Massachusetts
|
-$104K |